Šīs tīmekļa vietnes satura kvalitātes uzlabošanai un pielāgošanai lietotāju vajadzībām tiek lietotas sīkdatnes - tai skaitā arī trešo pušu sīkdatnes. Turpinot lietot šo vietni Jūs piekrītat sīkdatņu lietošanai.
In Nine Months “OlainFarm” Makes 6.4 Million in Net Profit
Emitents Olainfarm, AS (213800WCG52W62ENOP27)
Veids Finanšu pārskati
Valoda EN
Statuss Publicēts
Versija
Datums 2012-11-30 16:11:19
Versijas komentārs
Teksts

Olaine, November 30, 2012

 In Nine Months “OlainFarm” Makes 6.4 Million in Net Profit

Consolidated profit and loss account of AS „OlainFarm” for operations in nine months of 2012 shows that the concern continues
setting profit records as it has made the net profit of 6.4 million lats (9.1 million euros) in nine months.  This is an
increase by 27% compared to nine months on 2011 and almost ten times more than five years ago in 2007.  First nine months of
this year have been the most profitable in corporate history of AS “OlainFarm”.

“Nine months results of this year show that “OlainFarm” is surely on its way to become the leading producer of chemical and
pharmaceutical products in the Baltic states.  This is also confirmed by the award for “Top 500 EBITDA Maker” received last
week.  We are also very honoured that as "OlainFarm" celebrated its 40th Anniversary, President Andris Berzins of Latvia
awarded us with a special Certificate of Appreciation for Impressive Growth and Increase in Value,” says Valerijs Maligins,
Chairman of the Board of  AS "OlainFarm".

Sales of AS “OlainFarm” in nine months of  2012 have grown by 34% compared to the same period a year ago and reached 35.2
million lats (50 million euro).

During nine months of 2012 sales to all our key markets continued growing, except Belarus. The biggest sales increases were
achieved in Taiwan, where sales grew 8 times, in Latvia, where sales grew fourfold, the UK, where sales doubled and Russia,
where sales grew by 30%. Major sales markets of AS “OlainFarm” in nine months of 2012 were Russia, Latvia, Ukraine, Belarus,
Kazakhstan and the UK. 

According to budget and operating plan of AS “OlainFarm” for 2012, sales of the Concern in 2012 are planned to be 48 million
lats (68.3 million euros), but the net profit will reach 8.6 million lats (12.24 million euros).  According to this unaudited
report for 3 quarters of 2012, during the first nine months 73.3% of annual sales target and 74.2% of annual profit target is
met

________________________________________
A/s Olainfarm is one of the biggest pharmaceutical companies in Latvia with 40 years of experience in production of
medication and chemical and pharmaceutical products. A basic principle of company's operations is to produce reliable and
effective top quality products for Latvia and the rest of the world. Products made by the Group are being exported to more
than 30 countries of the world, including the Baltics, Russia, other CIS, Europe, Asia, North America and Australia. 
Information prepared by:

   Salvis Lapins
   Member of the Board
   A/s „Olainfarm”
  Tel: +371 6 7013 717
e-mail: Salvis.Lapins@olainfarm.lv

 

Pielikumi
Olainfarm_III_2012_eng_consolidated.pdf (1051.54 kB)